Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trialJ. Guigay, Franck Darloy, Olivier Capitain et al.|The Lancet Oncology|2021Cited by 231
Flap delineation guidelines in postoperative head and neck radiation therapy for head and neck cancersJennifer Le Guévelou, Juliette Thariat, X. Liem et al.|Radiotherapy and Oncology|2020Cited by 25